562 related articles for article (PubMed ID: 26408801)
1. Molecular and cellular mechanisms linking inflammation to insulin resistance and β-cell dysfunction.
Khodabandehloo H; Gorgani-Firuzjaee S; Panahi G; Meshkani R
Transl Res; 2016 Jan; 167(1):228-56. PubMed ID: 26408801
[TBL] [Abstract][Full Text] [Related]
2. Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance.
Lee BC; Lee J
Biochim Biophys Acta; 2014 Mar; 1842(3):446-62. PubMed ID: 23707515
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
[TBL] [Abstract][Full Text] [Related]
4. Tissue resident macrophages: Key players in the pathogenesis of type 2 diabetes and its complications.
Meshkani R; Vakili S
Clin Chim Acta; 2016 Nov; 462():77-89. PubMed ID: 27570063
[TBL] [Abstract][Full Text] [Related]
5. IL-37 protects against obesity-induced inflammation and insulin resistance.
Ballak DB; van Diepen JA; Moschen AR; Jansen HJ; Hijmans A; Groenhof GJ; Leenders F; Bufler P; Boekschoten MV; Müller M; Kersten S; Li S; Kim S; Eini H; Lewis EC; Joosten LA; Tilg H; Netea MG; Tack CJ; Dinarello CA; Stienstra R
Nat Commun; 2014 Sep; 5():4711. PubMed ID: 25182023
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of toll-like receptor 4 and inflammatory cytokines, interleukin-6 in particular, in islets from a mouse model of obesity and type 2 diabetes.
Ladefoged M; Buschard K; Hansen AM
APMIS; 2013 Jun; 121(6):531-8. PubMed ID: 23134512
[TBL] [Abstract][Full Text] [Related]
7. Resident macrophages mediate islet amyloid polypeptide-induced islet IL-1β production and β-cell dysfunction.
Westwell-Roper CY; Ehses JA; Verchere CB
Diabetes; 2014 May; 63(5):1698-711. PubMed ID: 24222351
[TBL] [Abstract][Full Text] [Related]
8. Molecular Events Linking Oxidative Stress and Inflammation to Insulin Resistance and β-Cell Dysfunction.
Keane KN; Cruzat VF; Carlessi R; de Bittencourt PI; Newsholme P
Oxid Med Cell Longev; 2015; 2015():181643. PubMed ID: 26257839
[TBL] [Abstract][Full Text] [Related]
9. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes.
Esser N; Legrand-Poels S; Piette J; Scheen AJ; Paquot N
Diabetes Res Clin Pract; 2014 Aug; 105(2):141-50. PubMed ID: 24798950
[TBL] [Abstract][Full Text] [Related]
10. Chemotactic cytokines, obesity and type 2 diabetes: in vivo and in vitro evidence for a possible causal correlation?
Sell H; Eckel J
Proc Nutr Soc; 2009 Nov; 68(4):378-84. PubMed ID: 19698204
[TBL] [Abstract][Full Text] [Related]
11. The "Big Bang" in obese fat: Events initiating obesity-induced adipose tissue inflammation.
Wensveen FM; Valentić S; Šestan M; Turk Wensveen T; Polić B
Eur J Immunol; 2015 Sep; 45(9):2446-56. PubMed ID: 26220361
[TBL] [Abstract][Full Text] [Related]
12. Adipose tissue macrophages.
Zeyda M; Stulnig TM
Immunol Lett; 2007 Oct; 112(2):61-7. PubMed ID: 17719095
[TBL] [Abstract][Full Text] [Related]
13. Insights into the role of macrophage migration inhibitory factor in obesity and insulin resistance.
Finucane OM; Reynolds CM; McGillicuddy FC; Roche HM
Proc Nutr Soc; 2012 Nov; 71(4):622-33. PubMed ID: 22914223
[TBL] [Abstract][Full Text] [Related]
14. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes.
Sullivan TJ; Miao Z; Zhao BN; Ertl LS; Wang Y; Krasinski A; Walters MJ; Powers JP; Dairaghi DJ; Baumgart T; Seitz LC; Berahovich RD; Schall TJ; Jaen JC
Metabolism; 2013 Nov; 62(11):1623-32. PubMed ID: 23953944
[TBL] [Abstract][Full Text] [Related]
15. Inflammation, cytokines and insulin resistance: a clinical perspective.
Wieser V; Moschen AR; Tilg H
Arch Immunol Ther Exp (Warsz); 2013 Apr; 61(2):119-25. PubMed ID: 23307037
[TBL] [Abstract][Full Text] [Related]
16. Decoding cell death signals in liver inflammation.
Brenner C; Galluzzi L; Kepp O; Kroemer G
J Hepatol; 2013 Sep; 59(3):583-94. PubMed ID: 23567086
[TBL] [Abstract][Full Text] [Related]
17. Increased GIP signaling induces adipose inflammation via a HIF-1α-dependent pathway and impairs insulin sensitivity in mice.
Chen S; Okahara F; Osaki N; Shimotoyodome A
Am J Physiol Endocrinol Metab; 2015 Mar; 308(5):E414-25. PubMed ID: 25537494
[TBL] [Abstract][Full Text] [Related]
18. TLR4 triggered complex inflammation in human pancreatic islets.
He W; Rebello O; Savino R; Terracciano R; Schuster-Klein C; Guardiola B; Maedler K
Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):86-97. PubMed ID: 30287405
[TBL] [Abstract][Full Text] [Related]
19. Metabolic inflammation: connecting obesity and insulin resistance.
Dali-Youcef N; Mecili M; Ricci R; Andrès E
Ann Med; 2013 May; 45(3):242-53. PubMed ID: 22834949
[TBL] [Abstract][Full Text] [Related]
20. Macrophages and islet inflammation in type 2 diabetes.
Eguchi K; Manabe I
Diabetes Obes Metab; 2013 Sep; 15 Suppl 3():152-8. PubMed ID: 24003932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
